I've been noticing something that's worth paying attention to right now. The S&P 500 has become incredibly concentrated, and honestly, it's creating some real risk for a lot of investors who don't realize it.

Here's what's happening. When people talk about the market doing well, they're usually talking about the S&P 500. But these days, if you're invested in the S&P 500, about 40% of your money is sitting in just 10 stocks. That's not diversification—that's concentration risk. The AI boom and the run-up in the Magnificent Seven has pulled so much capital into tech that it's distorted the whole index. Tech alone has nearly 35% weighting in the cap-weighted S&P 500. That's genuinely lopsided.

The problem is obvious when you think about it. If you're overweight tech in your portfolio and the market rotates away from those names, you're looking at a serious drawdown. A lot of investors don't realize how exposed they are until it's too late. That's why I think there's a best etf right now that most people are sleeping on.

The Invesco S&P 500 Equal Weight ETF (RSP) does something pretty elegant. Instead of weighting stocks by market cap like the regular S&P 500, it weights every single component equally. So stock 1 gets the same 0.2% weighting as stock 500. You still get 500 large-cap stocks, but the sector mix is completely different.

In RSP, the top five holdings break down like this: industrials at 15.6%, financials at 14.5%, technology at 14.4%, healthcare at 13.1%, and consumer discretionary at 9.4%. Compare that to the cap-weighted S&P 500 where tech dominates at 35%, and you can see why this approach matters. It's a fundamentally different portfolio while still staying in large-cap territory.

What's interesting is that the market is already starting to signal a rotation. Over the last couple of months, tech has actually lagged the S&P 500. Cyclicals and healthcare have moved into the leadership role. There are real reasons driving this.

First, interest rates have been falling. Smaller companies tend to carry more debt, so they benefit disproportionately when rates drop. That naturally helps the equal-weight approach since it has broader exposure beyond mega-cap tech. Second, there are signs of labor market stress, which points to potential economic growth concerns. When investors get nervous about growth, they typically rotate into defensive sectors like healthcare. Healthcare actually had the strongest performance in the S&P 500 last quarter by a wide margin. Third, and this is important, the momentum in tech looks like it's peaked. The AI boom drove incredible revenue and earnings growth, but that growth is starting to normalize. When growth slows in a sector that's been leading, investors tend to get more cautious. Right now, that's tech.

So why does RSP matter? It gives you a way to stay invested in large-cap equities while protecting yourself from concentration risk. If you believe tech momentum is slowing, if you think the sector is overvalued, or if you just want to reduce your portfolio's vulnerability to a tech pullback, this best etf right now lets you do that without abandoning large-cap exposure entirely.

The real advantage of equal-weighting is the discipline it builds in. You're not chasing whatever's hot. You're maintaining exposure across the entire market regardless of which sectors are leading. A lot of investors have made great money riding the tech wave, but that kind of dominance never lasts forever. Markets rotate. Sectors take turns leading. That's just how it works.

If you're sitting on a portfolio that's heavily weighted toward tech and you're starting to feel uncomfortable about it, RSP is worth a serious look. It's not about abandoning your conviction in equities. It's about smart positioning. You get the upside of 500 large-cap companies without the concentration risk that comes with the current market structure.

The best etf right now for rotation positioning is one that lets you participate in whatever area of the market is leading, not just the one that led last year. That's what makes RSP interesting. Whether cyclicals keep running, healthcare continues its defensive outperformance, or we eventually see a rebalancing back toward tech, you're positioned to benefit from the shift.

For investors who want to stay in equities but are getting nervous about how top-heavy the market has become, RSP looks like a smart move. It's the kind of position that might not grab headlines, but it could save you from significant downside if the market finally starts to broaden out. That's why I think this one deserves more attention than it's getting right now.